Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

Yung‐Jue Bang, Narikazu Boku, Shukui Qin et al.|The Lancet Oncology|2017

Cited by 291